# Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

> **NCT00449553** · — · COMPLETED · sponsor: **Takeda** · enrollment: 326 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone and sulphonylurea
- **DRUG:** Pioglitazone and sulphonylurea
- **DRUG:** Pioglitazone and metformin
- **DRUG:** Pioglitazone and metformin

## Key facts

- **NCT ID:** NCT00449553
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2012-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449553, "Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00449553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*